Results 241 to 250 of about 250,975 (359)

Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling [PDF]

, 2004
Douglas R. Bolster, Leonard S. Jefferson, Scot R. Kimball   +2 more
openalex   +1 more source

Homemade and Handmade

Journal of General and Family Medicine, EarlyView.
Junki Mizumoto, Taro Shimizu
wiley   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Satellite cell dynamics during skeletal muscle hypertrophy. [PDF]

Biochem Soc Trans
Saliu TP, Goh J, Kang G, Burke BI, Ismaeel A, McCarthy JJ.   +5 more
europepmc   +1 more source

Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy [PDF]

, 2004
Stephanie A. Parsons, Douglas P. Millay, Benjamin J. Wilkins, Orlando F. Bueno, Gretchen L. Tsika, Joel R. Neilson, Christine M. Liberatore, Katherine E. Yutzey, Robert H. Crabtree, R. W. Tsika, Jeffery D. Molkentin   +10 more
openalex   +1 more source

Analysis of a Modified Version of the Inventory of Non‐Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the EFACTS Study

Movement Disorders, EarlyView.
Abstract Background Friedreich's ataxia is a rare, neurodegenerative, multisystem disorder. While ataxia is a hallmark, non‐ataxia signs, including muscle weakness, spasticity, and dysphagia are equally disabling. The Inventory of Non‐Ataxia Signs (INAS) is a symptom list transformable to a 16‐item count.
Stella Andrea Lischewski, Imis Dogan, Paola Giunti, Michael H. Parkinson, Caterina Mariotti, Alexandra Durr, Claire Ewenczyk, Sylvia Boesch, Wolfgang Nachbauer, Thomas Klopstock, Claudia Stendel, Francisco Javier Rodríguez de Rivera Garrido, Ludger Schöls, Zofia Fleszar, Thomas Klockgether, Marcus Grobe‐Einsler, Ilaria Giordano, Myriam Rai, Massimo Pandolfo, Heike Jacobi, Ralf‐Dieter Hilgers, Jörg B. Schulz, Kathrin Reetz, on behalf of the EFACTS Study Group   +23 more
wiley   +1 more source

Correction: The effects of blood flow restriction combined with resistance training on lower limb strength, muscle hypertrophy, jumping ability, and sprint speed in athletes: a systematic review and meta-analysis. [PDF]

Front Physiol
Deng B, Lin G, Shi Y, Li D, Guan Z, Liang C, Sun J.   +6 more
europepmc   +1 more source

[Neurogenic muscle hypertrophy].

Revista de neurologia, 2016
Garcia-Atienza, EM, Sanchez-Tejero, EA, Godes-Medrano, B, Agudo-Mena, JL, Campos-Garcia, J, Lopez, JLT   +5 more
openaire   +2 more sources

A congenital dermal sinus presenting the muscle fasciculation and hypertrophy

, 2001
Masaaki Takahashi, Hideyuki Murata, Tomohiro Ohmura, Akira Nagano   +3 more
openalex   +1 more source

Modulators of Diacylglycerol Kinase Activity: A Review of Advances and Challenges

Medicinal Research Reviews, EarlyView.
ABSTRACT Catalyzing the conversion of diacylglycerol (DAG) in phosphatidic acid (PA), diacylglycerol kinases (DGKs) play a pivotal role in all the physiological processes modulated by these two bioactive lipids, such as lipid metabolism and immune regulation.
Luisa Racca, Gianluca Baldanzi, Alberto Massarotti   +2 more
wiley   +1 more source